Aphria Inc (TSX:APHA) (NYSE:APHA) announced Wednesday that its Colombian subsidiary, Colcanna SAS is partnering with the Federación Médica Colombiana, a national guild that oversees the ethics of the medical profession in Colombia, to develop an academic curriculum on the medicinal use of cannabis.
The new guidance will offer Colombia’s doctors and medical professionals a credible source of information on medical cannabis. The Federación Médica Colombiana (FMC) has nearly 2,000 affiliated doctors as well as more than 70,000 medical professionals who access the organization's materials for research and education.
READ: Aphria reports higher 1Q fiscal first quarter revenue and looks ahead to cannabis legalization in Canada
The medical cannabis curriculum developed by Colcanna and FMC will be made accessible on FMC’s online platform which offers courses on a range of subjects.
“Education in the medical community is critical for sustaining the advancement of medical cannabis in Colombia,” said Gabriel Meneses, vice-president for Latin America and the Caribbean with Aphria in a statement.
Headquartered in Leamington, Ontario, Aphria produces and sells medical cannabis in Canada and internationally.
Aphria shares were down slightly in pre-market trading in New York on Wednesday, slipping by 0.7% to hit $5.65.
Contact Ellen Kelleher at [email protected]